Shares of Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Free Report) traded down 2.3% on Friday . The company traded as low as $0.38 and last traded at $0.39. 27,512 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 119,612 shares. The stock had previously closed at $0.40.
Shuttle Pharmaceuticals Stock Performance
The stock has a fifty day simple moving average of $0.41 and a two-hundred day simple moving average of $0.45. The stock has a market cap of $6.55 million, a price-to-earnings ratio of -0.91 and a beta of -1.13. The company has a debt-to-equity ratio of 0.03, a quick ratio of 5.37 and a current ratio of 5.37.
Shuttle Pharmaceuticals (NASDAQ:SHPH – Get Free Report) last issued its earnings results on Thursday, March 21st. The company reported ($0.10) earnings per share for the quarter.
Shuttle Pharmaceuticals Company Profile
Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers.
Recommended Stories
- Five stocks we like better than Shuttle Pharmaceuticals
- Best Stocks Under $5.00
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is the Dogs of the Dow Strategy? Overview and Examples
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Stock Average Calculator
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.